Literature DB >> 30376482

Computed Tomography and Magnetic Resonance Imaging of Cardiovascular Anomalies Associated With Turner Syndrome.

Christopher J G Sigakis1, Lorna P Browne2, Tami Bang3, Amber Khanna4, Ryan Pruente3, Daniel Vargas3.   

Abstract

Cardiovascular imaging plays a central role in the diagnosis, management, and follow-up of congenital and acquired cardiovascular disease in patients with Turner syndrome. Cardiovascular defects in this population may affect a single component of the cardiovascular system or exist in combination with other anomalies, and, they may present early in life or remain occult into adulthood. Careful screening and surveillance imaging are necessary for the early detection and management of cardiovascular defects, especially in cases wherein early intervention may be necessary to prevent a serious cardiovascular outcome. It is critical that these patients are followed-up by specialists aware of their unique cardiovascular risk factors and that imaging examinations are interpreted by cardiovascular imagers familiar with the variety of anomalies that may be present and/or warrant imaging follow-up. Herein, we review common and uncommon cardiovascular anomalies associated with Turner syndrome and provide an image-based approach to analyzing key cardiothoracic findings that should be assessed in this patient population. Current imaging recommendations and guidelines for various anomalies will also be reviewed.

Entities:  

Mesh:

Year:  2019        PMID: 30376482     DOI: 10.1097/RTI.0000000000000372

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  1 in total

1.  Four-dimensional Flow Magnetic Resonance Imaging Quantification of Blood Flow in Bicuspid Aortic Valve.

Authors:  Daniel Z Gordon; Muhannad A Abbasi; Jeesoo Lee; Roberto Sarnari; Alireza Sojoudi; Qiao Wei; Michael B Scott; Jeremy D Collins; Bradley D Allen; Julie A Blaisdell; James C Carr; Michael Markl
Journal:  J Thorac Imaging       Date:  2020-11-01       Impact factor: 5.528

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.